Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lubricoat 0 data

LCBM summarized data from its open-label, randomized, placebo-controlled pilot trial of Lubricoat in women undergoing peritoneal

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE